Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Predicting breast cancer 5-year survival using machine learning: A systematic review.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
- بيانات النشر:
Original Publication: San Francisco, CA : Public Library of Science
- الموضوع:
- نبذة مختصرة :
Background: Accurately predicting the survival rate of breast cancer patients is a major issue for cancer researchers. Machine learning (ML) has attracted much attention with the hope that it could provide accurate results, but its modeling methods and prediction performance remain controversial. The aim of this systematic review is to identify and critically appraise current studies regarding the application of ML in predicting the 5-year survival rate of breast cancer.
Methods: In accordance with the PRISMA guidelines, two researchers independently searched the PubMed (including MEDLINE), Embase, and Web of Science Core databases from inception to November 30, 2020. The search terms included breast neoplasms, survival, machine learning, and specific algorithm names. The included studies related to the use of ML to build a breast cancer survival prediction model and model performance that can be measured with the value of said verification results. The excluded studies in which the modeling process were not explained clearly and had incomplete information. The extracted information included literature information, database information, data preparation and modeling process information, model construction and performance evaluation information, and candidate predictor information.
Results: Thirty-one studies that met the inclusion criteria were included, most of which were published after 2013. The most frequently used ML methods were decision trees (19 studies, 61.3%), artificial neural networks (18 studies, 58.1%), support vector machines (16 studies, 51.6%), and ensemble learning (10 studies, 32.3%). The median sample size was 37256 (range 200 to 659820) patients, and the median predictor was 16 (range 3 to 625). The accuracy of 29 studies ranged from 0.510 to 0.971. The sensitivity of 25 studies ranged from 0.037 to 1. The specificity of 24 studies ranged from 0.008 to 0.993. The AUC of 20 studies ranged from 0.500 to 0.972. The precision of 6 studies ranged from 0.549 to 1. All of the models were internally validated, and only one was externally validated.
Conclusions: Overall, compared with traditional statistical methods, the performance of ML models does not necessarily show any improvement, and this area of research still faces limitations related to a lack of data preprocessing steps, the excessive differences of sample feature selection, and issues related to validation. Further optimization of the performance of the proposed model is also needed in the future, which requires more standardization and subsequent validation.
Competing Interests: The authors have declared that no competing interests exist.
- References:
JAMA. 1997 Feb 12;277(6):488-94. (PMID: 9020274)
Cancer Inform. 2018 Nov 09;17:1176935118810215. (PMID: 30455569)
BMJ. 1994 Nov 19;309(6965):1351-5. (PMID: 7866085)
Eur Urol. 2015 Jun;67(6):1142-1151. (PMID: 25572824)
Int J Med Inform. 2020 Sep;141:104170. (PMID: 32544823)
J Med Syst. 2015 Nov;39(11):152. (PMID: 26385549)
PLoS Med. 2014 Oct 14;11(10):e1001744. (PMID: 25314315)
BMC Med Inform Decis Mak. 2013 Nov 09;13:124. (PMID: 24207108)
IEEE/ACM Trans Comput Biol Bioinform. 2018 Feb 15;:. (PMID: 29994639)
BMC Med. 2020 Nov 17;18(1):327. (PMID: 33198768)
BMC Med Res Methodol. 2014 Dec 22;14:137. (PMID: 25532820)
J Am Med Inform Assoc. 2013 Jul-Aug;20(4):613-8. (PMID: 23467471)
IEEE Trans Biomed Eng. 2018 Nov 22;:. (PMID: 30475709)
Int J Med Inform. 2020 Nov;143:104268. (PMID: 32950874)
Artif Intell Med. 2005 Jun;34(2):113-27. (PMID: 15894176)
Int J Med Inform. 2019 Oct;130:103957. (PMID: 31472443)
J Med Syst. 2014 Oct;38(10):106. (PMID: 25119239)
Breast Cancer Res Treat. 1994;30(2):117-26. (PMID: 7949209)
J Am Med Inform Assoc. 2020 Jul 1;27(7):1092-1101. (PMID: 32548642)
BMC Med Inform Decis Mak. 2019 Mar 22;19(1):48. (PMID: 30902088)
Endocr Connect. 2019 Jul;8(7):952-960. (PMID: 31234143)
J Natl Cancer Inst. 2020 Oct 1;112(10):979-988. (PMID: 32259259)
PLoS One. 2016 May 19;11(5):e0155119. (PMID: 27195952)
Artif Intell Med. 2018 Aug;90:1-14. (PMID: 30017512)
J Clin Epidemiol. 2019 Jun;110:12-22. (PMID: 30763612)
Eur J Cardiothorac Surg. 2013 Jun;43(6):1146-52. (PMID: 23152436)
Radiology. 2020 Feb;294(2):265-272. (PMID: 31845842)
Ann Intern Med. 2019 Jan 1;170(1):W1-W33. (PMID: 30596876)
Glob J Health Sci. 2015 Jan 26;7(4):392-8. (PMID: 25946945)
N Engl J Med. 2016 Sep 29;375(13):1216-9. (PMID: 27682033)
Breast Cancer Res Treat. 2018 Dec;172(3):611-618. (PMID: 30194511)
Breast Cancer Res. 2020 May 28;22(1):57. (PMID: 32466777)
J Biomed Inform. 2014 Dec;52:418-26. (PMID: 25182868)
Ann Oncol. 2007 Jun;18(6):971-6. (PMID: 17043092)
J Res Health Sci. 2016 Winter;16(1):31-5. (PMID: 27061994)
Cancer Invest. 2009 Mar;27(3):235-43. (PMID: 19291527)
Comput Struct Biotechnol J. 2014 Nov 15;13:8-17. (PMID: 25750696)
J Intern Med. 2020 Jul;288(1):62-81. (PMID: 32128929)
BMC Med Res Methodol. 2014 Mar 19;14:40. (PMID: 24645774)
Comput Methods Programs Biomed. 2018 Mar;156:25-45. (PMID: 29428074)
Mol Psychiatry. 2020 Dec;25(12):3186-3197. (PMID: 32820237)
Comput Methods Programs Biomed. 2018 Jul;161:45-53. (PMID: 29852967)
J Clin Invest. 2011 Oct;121(10):3786-8. (PMID: 21965334)
Stat Med. 2000 Feb 29;19(4):453-73. (PMID: 10694730)
Oncologist. 2004;9(6):606-16. (PMID: 15561805)
BMC Med Genomics. 2014;7 Suppl 1:S4. (PMID: 25080202)
Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:5148-51. (PMID: 19163876)
Artif Intell Med. 2020 Nov;110:101977. (PMID: 33250149)
BMC Cancer. 2019 Mar 14;19(1):230. (PMID: 30871490)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:1290-3. (PMID: 24109931)
Comput Biol Med. 2015 Apr;59:125-133. (PMID: 25725446)
Comput Methods Programs Biomed. 2020 Aug;192:105458. (PMID: 32302875)
Epidemiology. 2010 Jan;21(1):128-38. (PMID: 20010215)
J Med Internet Res. 2019 Jul 26;21(7):e14464. (PMID: 31350843)
Folia Biol (Praha). 2019;65(5-6):212-220. (PMID: 32362304)
Am J Epidemiol. 2010 Oct 15;172(8):971-80. (PMID: 20807737)
Int J Epidemiol. 1999 Feb;28(1):1-9. (PMID: 10195657)
- الموضوع:
Date Created: 20210416 Date Completed: 20210929 Latest Revision: 20210929
- الموضوع:
20240628
- الرقم المعرف:
PMC8051758
- الرقم المعرف:
10.1371/journal.pone.0250370
- الرقم المعرف:
33861809
No Comments.